Molecular assessment of intratumoral immune cell subsets and potential mechanisms of resistance to odronextamab, a CD20×CD3 bispecific antibody, in patients with relapsed/refractory B-cell non-Hodgkin lymphoma
==================================================================================================================================================================================================================

* Jurriaan Brouwer-Visser
* Nathalie Fiaschi
* Raquel P Deering
* Kamil J Cygan
* Darius Scott
* Se Jeong
* Lauren Boucher
* Namita T Gupta
* Suraj Gupta
* Christina Adler
* Max S Topp
* Rajat Bannerji
* Johannes Duell
* Ranjana H Advani
* Dina M Flink
* Aafia Chaudhry
* Gavin Thurston
* Srikanth R Ambati
* Vladimir Jankovic